Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil

Autor: Pfeiffer, P. *, Sørbye, H., Ehrsson, H., Fokstuen, T., Mortensen, J.P., Baltesgard, L., Tveit, K.M., Øgreid, D., Starkhammar, H., Wallin, I., Qvortrup, C., Glimelius, B.
Zdroj: In Annals of Oncology February 2006 17(2):252-258
Databáze: ScienceDirect